Press Release
Category Added in a WPeMatico Campaign
-
Kyndryl Launches AI-Powered Digital Twin for the Workplace
Built on Microsoft Foundry, Kyndryl’s solution helps enterprises predict, prevent and resolve technology disruptions NEW YORK, April 9, 2026…
Read More » -
VELUX Skylight System Named Sustainable Product of the Year by Green Builder Media
Recognition honors innovation in energy efficiency, daylighting, and healthier home design FORT MILL, S.C., April 9, 2026 /PRNewswire/ — VELUX, the…
Read More » -
TEAM GROUP ANNOUNCES ACQUISITION OF A&J VACWORX, EXPANDING INDUSTRIAL SERVICES PLATFORM
AURORA, ON, April 9, 2026 /CNW/ – TEAM Group Inc. (“TEAM Group”), a leading North American provider of integrated industrial…
Read More » -
Host City Bids Open for The Games Of The Future 2028 to 2030
Phygital International opens host city bidding, inviting cities to take a leading role in the future of sport as phygital…
Read More » -
Privacy and Data Security Litigator Elisabeth Hutchinson Rejoins Shook as Partner in Denver
DENVER, April 9, 2026 /PRNewswire/ — Shook, Hardy & Bacon bolstered its national Chambers-ranked Privacy and Cybersecurity Practice with the addition…
Read More » -
CB&I Completes Acquisition of Petrofac Asset Solutions Business
THE WOODLANDS, Texas, April 9, 2026 /PRNewswire/ — CB&I today announced the completion of an asset sale agreement, previously announced on…
Read More » -
KLG Business Valuators & Forensic Accountants, LLC, Combines with EisnerAmper
Premier Litigation Support Firm Has Decades of Business Valuation and Forensic Accounting Expertise NEW YORK, April 9, 2026 /PRNewswire/ —…
Read More » -
KLG Business Valuators & Forensic Accountants, LLC, Combines with EisnerAmper
Premier Litigation Support Firm Has Decades of Business Valuation and Forensic Accounting Expertise NEW YORK, April 9, 2026 /PRNewswire/ —…
Read More » -
Anixa Biosciences to Participate in RedChip’s Biotech Resurgence: Platforms and Pipelines of Today’s Innovators Conference on April 16, 2026
Breast cancer vaccine met primary endpoints and generated protocol-defined immuneresponses in 74% of participants in Phase 1 clinical trial Ovarian…
Read More »